BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8032948)

  • 1. Effects of systemically administered ceruletide on the in vivo release and metabolism of dopamine in the medial prefrontal cortex of awake, freely moving rats: an in vivo microdialysis study.
    Hagino Y; Moroji T
    Brain Res; 1994 Apr; 644(1):40-6. PubMed ID: 8032948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceruletide inhibits phencyclidine-induced dopamine and serotonin release in rat prefrontal cortex.
    Etou K; Kuroki T; Kawahara T; Yonezawa Y; Tashiro N; Uchimura H
    Pharmacol Biochem Behav; 1998 Dec; 61(4):427-34. PubMed ID: 9802838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceruletide, a CCK-like peptide, attenuates dopamine release from the rat striatum via a central site of action.
    Kihara T; Ikeda M; Ibii N; Matsushita A
    Brain Res; 1992 Aug; 588(2):270-6. PubMed ID: 1393578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceruletide suppresses endogenous dopamine release via vagal afferent system, studied by in vivo intracerebral dialysis.
    Hamamura T; Kazahaya Y; Otsuki S
    Brain Res; 1989 Mar; 483(1):78-83. PubMed ID: 2706512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and chronic clozapine on dopaminergic function in medial prefrontal cortex of awake, freely moving rats.
    Chen JP; Ruan D; Paredes W; Gardner EL
    Brain Res; 1992 Feb; 571(2):235-41. PubMed ID: 1611497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats.
    You ZB; Tzschentke TM; Brodin E; Wise RA
    J Neurosci; 1998 Aug; 18(16):6492-500. PubMed ID: 9698337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat.
    Cartmell J; Perry KW; Salhoff CR; Monn JA; Schoepp DD
    J Neurochem; 2000 Sep; 75(3):1147-54. PubMed ID: 10936197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CCK8 and of the CCKB-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Ladurelle N; Keller G; Roques BP; Daugé V
    Brain Res; 1993 Nov; 628(1-2):254-62. PubMed ID: 8313154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of systemically administered caerulein on dopamine metabolism in rat brain.
    Matsumoto T; Nakahara T; Uchimura H; Hirano M; Yokoo H; Nakamura K; Oomagari K
    Brain Res; 1984 Dec; 324(1):195-9. PubMed ID: 6518389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ceruletide and haloperidol on the hypothalamo-pituitary beta-endorphin system and brain beta-endorphin contents in the rat: with special reference to effects of ceruletide in chronically haloperidol-treated rats.
    Hagino Y; Okuwa M; Moroji T
    Neuropeptides; 1991 Jan; 18(1):1-14. PubMed ID: 2046884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
    Kihara T; Ikeda M; Matsubara K; Matsushita A
    Eur J Pharmacol; 1993 Jan; 230(3):271-7. PubMed ID: 8440305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
    Ballarín M; Carceller A; Guitart X
    Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characterization of the effect of locally applied N-methylquipazine, a 5-HT3 receptor agonist, on extracellular dopamine levels in the anterior medial prefrontal cortex in the rat: an in vivo microdialysis study.
    Kurata K; Ashby CR; Oberlender R; Tanii Y; Kurachi M; Rini NJ; Strecker RE
    Synapse; 1996 Dec; 24(4):313-21. PubMed ID: 10638822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.
    Uehara T; Tanii Y; Sumiyoshi T; Kurachi M
    Brain Res; 2000 Mar; 860(1-2):77-86. PubMed ID: 10727625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of potassium concentration in microdialysis perfusate on basal and stimulated striatal dopamine release: effect of ceruletide, a cholecystokinin-related peptide.
    Kihara T; Ikeda M; Miyazaki H; Matsushita A
    J Neurochem; 1993 Nov; 61(5):1859-64. PubMed ID: 8228999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of endogenous glutamate on extracellular concentrations of GABA, dopamine, and dopamine metabolites in the prefrontal cortex of the freely moving rat: involvement of NMDA and AMPA/KA receptors.
    Del Arco A; Mora F
    Neurochem Res; 1999 Aug; 24(8):1027-35. PubMed ID: 10478942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and chronic lithium treatment on amphetamine-induced dopamine increase in the nucleus accumbens and prefrontal cortex in rats as studied by microdialysis.
    Baptista T; Teneúd L; Contreras Q; Burguera JL; Burguera M; Hernández L
    J Neural Transm Gen Sect; 1993; 94(2):75-89. PubMed ID: 7509157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Kariya K; Tanaka J; Nomura M
    Brain Res; 1994 Sep; 657(1-2):1-6. PubMed ID: 7820607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain.
    Ge J; Long SK; Kilpatrick IC
    Eur J Pharmacol; 1998 Mar; 345(2):163-70. PubMed ID: 9600632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®.
    Kehr J; Yoshitake S; Ijiri S; Koch E; Nöldner M; Yoshitake T
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S25-34. PubMed ID: 22784425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.